Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Modulation of Serum Brain-Derived Neurotrophic Factor by a Single Dose of Ayahuasca: Observation From a Randomized Controlled Trial
Raíssa Nóbrega de Almeida, Ana Cecília de Menezes Galvão, Flávia Santos da Silva, et al.
Frontiers in Psychology (2019) Vol. 10
Open Access | Times Cited: 142

Showing 1-25 of 142 citing articles:

Acute dose-dependent effects of lysergic acid diethylamide in a double-blind placebo-controlled study in healthy subjects
Friederike Holze, Patrick Vizeli, Laura Ley, et al.
Neuropsychopharmacology (2020) Vol. 46, Iss. 3, pp. 537-544
Open Access | Times Cited: 177
Towards an understanding of psychedelic-induced neuroplasticity
Abigail E. Calder, Gregor Hasler
Neuropsychopharmacology (2022) Vol. 48, Iss. 1, pp. 104-112
Open Access | Times Cited: 173
Psychedelics and Neuroplasticity: A Systematic Review Unraveling the Biological Underpinnings of Psychedelics
Cato M. H. de Vos, Natasha L. Mason, Kim P. C. Kuypers
Frontiers in Psychiatry (2021) Vol. 12
Open Access | Times Cited: 168
Psychedelics in Psychiatry: Neuroplastic, Immunomodulatory, and Neurotransmitter Mechanisms
Antonio Inserra, Danilo De Gregorio, Gabriella Gobbi
Pharmacological Reviews (2020) Vol. 73, Iss. 1, pp. 202-277
Open Access | Times Cited: 156
Direct comparison of the acute effects of lysergic acid diethylamide and psilocybin in a double-blind placebo-controlled study in healthy subjects
Friederike Holze, Laura Ley, Felix Müller, et al.
Neuropsychopharmacology (2022) Vol. 47, Iss. 6, pp. 1180-1187
Open Access | Times Cited: 144
Acute Effects of Psilocybin After Escitalopram or Placebo Pretreatment in a Randomized, Double‐Blind, Placebo‐Controlled, Crossover Study in Healthy Subjects
A. Becker, Friederike Holze, Tanja Grandinetti, et al.
Clinical Pharmacology & Therapeutics (2021) Vol. 111, Iss. 4, pp. 886-895
Open Access | Times Cited: 128
Classic serotonergic psychedelics for mood and depressive symptoms: a meta-analysis of mood disorder patients and healthy participants
Nicole Leite Galvão‐Coelho, Wolfgang Marx, Maria Gonzalez, et al.
Psychopharmacology (2021) Vol. 238, Iss. 2, pp. 341-354
Open Access | Times Cited: 117
Pharmacological, neural, and psychological mechanisms underlying psychedelics: A critical review
Michiel van Elk, David B. Yaden
Neuroscience & Biobehavioral Reviews (2022) Vol. 140, pp. 104793-104793
Open Access | Times Cited: 106
Acute effects of intravenous DMT in a randomized placebo-controlled study in healthy participants
Severin B. Vogt, Laura Ley, Livio Erne, et al.
Translational Psychiatry (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 47
The Psychedelic Future of Post-Traumatic Stress Disorder Treatment
Tamar Glatman Zaretsky, Kathleen M. Jagodnik, Robert Barsic, et al.
Current Neuropharmacology (2024) Vol. 22, Iss. 4, pp. 636-735
Open Access | Times Cited: 15
Benefits and Challenges of Ultra-Fast, Short-Acting Psychedelics in the Treatment of Depression
Johannes G. Ramaekers, Johannes T. Reckweg, Natasha L. Mason
American Journal of Psychiatry (2025) Vol. 182, Iss. 1, pp. 33-46
Closed Access | Times Cited: 1
Persisting Reductions in Cannabis, Opioid, and Stimulant Misuse After Naturalistic Psychedelic Use: An Online Survey
Albert Garcia‐Romeu, Alan K. Davis, Earth Erowid, et al.
Frontiers in Psychiatry (2020) Vol. 10
Open Access | Times Cited: 112
Therapeutic use of serotoninergic hallucinogens: A review of the evidence and of the biological and psychological mechanisms
Rafael G. dos Santos, Jaime E. C. Hallak
Neuroscience & Biobehavioral Reviews (2019) Vol. 108, pp. 423-434
Closed Access | Times Cited: 107
Changes in inflammatory biomarkers are related to the antidepressant effects of Ayahuasca
Nicole Leite Galvão‐Coelho, Ana Cecília de Menezes Galvão, Raíssa Nóbrega de Almeida, et al.
Journal of Psychopharmacology (2020) Vol. 34, Iss. 10, pp. 1125-1133
Closed Access | Times Cited: 102
Low Doses of LSD Acutely Increase BDNF Blood Plasma Levels in Healthy Volunteers
Nadia R. P. W. Hutten, Natasha L. Mason, Patrick C. Dolder, et al.
ACS Pharmacology & Translational Science (2020) Vol. 4, Iss. 2, pp. 461-466
Open Access | Times Cited: 98
Chronic pain and psychedelics: a review and proposed mechanism of action
Joel Castellanos, C. Leonard Woolley, Kelly Bruno, et al.
Regional Anesthesia & Pain Medicine (2020) Vol. 45, Iss. 7, pp. 486-494
Closed Access | Times Cited: 89
Ketamine and Serotonergic Psychedelics: Common Mechanisms Underlying the Effects of Rapid-Acting Antidepressants
Bashkim Kadriu, Maximillian Greenwald, Ioline D. Henter, et al.
The International Journal of Neuropsychopharmacology (2020) Vol. 24, Iss. 1, pp. 8-21
Open Access | Times Cited: 81
Ayahuasca Improves Self-perception of Speech Performance in Subjects With Social Anxiety Disorder
Rafael G. dos Santos, Flávia de Lima Osório, Juliana Mendes Rocha, et al.
Journal of Clinical Psychopharmacology (2021) Vol. 41, Iss. 5, pp. 540-550
Closed Access | Times Cited: 66
Novel drug developmental strategies for treatment‐resistant depression
Éva Borbély, Mária Simon, Eberhard Fuchs, et al.
British Journal of Pharmacology (2021) Vol. 179, Iss. 6, pp. 1146-1186
Open Access | Times Cited: 65
Classic Psychedelic Drugs: Update on Biological Mechanisms
Franz X. Vollenweider, John Smallridge
Pharmacopsychiatry (2022) Vol. 55, Iss. 03, pp. 121-138
Open Access | Times Cited: 61
Effects of nutritional interventions on BDNF concentrations in humans: a systematic review
Elske Gravesteijn, Ronald P. Mensink, Jogchum Plat
Nutritional Neuroscience (2021) Vol. 25, Iss. 7, pp. 1425-1436
Open Access | Times Cited: 59
Clinical and biological predictors of psychedelic response in the treatment of psychiatric and addictive disorders: A systematic review
Bruno Roméo, Marianne Hermand, Amélie Petillion, et al.
Journal of Psychiatric Research (2021) Vol. 137, pp. 273-282
Open Access | Times Cited: 59
The clinical pharmacology and potential therapeutic applications of 5‐methoxy‐N,N‐dimethyltryptamine (5‐MeO‐DMT)
Johannes T. Reckweg, Malin V. Uthaug, Attila Szabó, et al.
Journal of Neurochemistry (2022) Vol. 162, Iss. 1, pp. 128-146
Open Access | Times Cited: 58
Repeated lysergic acid diethylamide (LSD) reverses stress-induced anxiety-like behavior, cortical synaptogenesis deficits and serotonergic neurotransmission decline
Danilo De Gregorio, Antonio Inserra, Justine P. Enns, et al.
Neuropsychopharmacology (2022) Vol. 47, Iss. 6, pp. 1188-1198
Open Access | Times Cited: 58
Ayahuasca use and reported effects on depression and anxiety symptoms: An international cross-sectional study of 11,912 consumers
Jerome Sarris, Daniel Perkins, Lachlan Cribb, et al.
Journal of Affective Disorders Reports (2021) Vol. 4, pp. 100098-100098
Open Access | Times Cited: 55
Page 1 - Next Page

Scroll to top